Clinical Trial Update: A Study of Capecitabine (Xeloda) in Patients With Metastatic Colorectal Cancer [Phase 4]

View source ↗

Summary

This document reports the completion of a Phase 4 clinical trial evaluating capecitabine (Xeloda) in patients with metastatic colorectal cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Capecitabine (Xeloda) (Capecitabine)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Colorectal Cancer | Phase 4 | Status: COMPLETED